Author

C. Puerner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:fungi (other)· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. S. Ross· 1 shared C. Pavuluri· 1 shared E. M. Vesely· 1 shared J. T. Jones· 1 shared K. A. Morelli· 1 shared M. J. Bromley· 1 shared N. v. Rhijn· 1 shared R. A. Cramer· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. S. Ross

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The Cystic Fibrosis treatment, Trikafta, affects growth, viability, and cell wall of Aspergillus fumigatus biofilms

J. T. Jones, K. A. Morelli, E. M. Vesely, C. Puerner, C. Pavuluri, B. S. Ross, N. v. Rhijn, M. J. Bromley, R. A. Cramer

This study shows Trikafta reduces A. fumigatus biofilm biomass, viability, and metabolic activity, while increasing susceptibility to antifungal drugs.

bioRxiv · Jun 20, 2023 · PreprintMicrobiology